Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

China · Delayed Price · Currency is CNY

34.06

-1.16 (-3.29%)

May 20, 2026, 2:55 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2020	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biopharma			157.70M	158.65M	185.75M	-	-
Biopharma Growth			-0.59%	-14.59%	-	-	-
Other			5.08M	9.85M	45.39M	-	-
Other Growth			-48.43%	-78.30%	-	-	-
Production and Sales of Raw Materials and Pharmaceutical Intermediates			48.80M	200.72M	102.26M	-	-
Production and Sales of Raw Materials and Pharmaceutical Intermediates Growth			-75.69%	96.29%	-	-	-
Medical Technical Services Reporting Segment			390.70M	319.40M	281.29M	-	-
Medical Technical Services Reporting Segment Growth			22.32%	13.55%	-	-	-
Total			602.28M	688.63M	614.68M	-	-
Total Growth			-12.54%	12.03%	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2020	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China			602.23M	684.49M	605.73M	524.12M	620.16M
China Growth			-12.02%	13.00%	15.57%	-15.49%	4.96%
Overseas			58.90K	4.13M	8.96M	-	-
Overseas Growth			-98.58%	-53.86%	-	-	-
Total			602.28M	688.63M	614.68M	524.12M	620.16M
Total Growth			-12.54%	12.03%	17.28%	-15.49%	4.96%

Source: S&P Global Market Intelligence.